Arrowhead Pharmaceuticals, Inc. (ARWR)
NASDAQ: ARWR · Real-Time Price · USD
18.31
-0.55 (-2.92%)
Jul 11, 2025, 4:00 PM - Market closed
Arrowhead Pharmaceuticals Employees
Arrowhead Pharmaceuticals had 609 employees as of September 30, 2024. The number of employees increased by 84 or 16.00% compared to the previous year.
Employees
609
Change (1Y)
84
Growth (1Y)
16.00%
Revenue / Employee
$895,253
Profits / Employee
-$236,402
Market Cap
2.53B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ARWR News
- 4 days ago - Arrowhead Pharmaceuticals Initiates Phase 3 YOSEMITE Study of Investigational Zodasiran for the Treatment of Homozygous Familial Hypercholesterolemia - Business Wire
- 19 days ago - Arrowhead Pharmaceuticals Completes Enrollment in SHASTA-3, SHASTA-4, and MUIR-3 Phase 3 Studies of Plozasiran - Business Wire
- 5 weeks ago - Jim Cramer: Arrowhead Pharmaceuticals Doesn't 'Have The Horses' - Benzinga
- 5 weeks ago - Arrowhead Pharmaceuticals Initiates Phase 1/2a Study of ARO-ALK7 for the Treatment of Obesity - Business Wire
- 6 weeks ago - Arrowhead Pharmaceuticals to Participate in June 2025 Investor Conferences - Business Wire
- 2 months ago - Arrowhead Pharmaceuticals, Inc. (ARWR) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Arrowhead Pharmaceuticals Reports Fiscal 2025 Second Quarter Results - Business Wire
- 2 months ago - Arrowhead Pharmaceuticals to Participate in May 2025 Investor Conferences - Business Wire